Medical College of Wisconsin
CTSIResearch InformaticsREDCap

Hematopoietic stem cell transplantation in adults with acute myeloid leukemia. Biol Blood Marrow Transplant 2008 May;14(5):556-67

Date

04/16/2008

Pubmed ID

18410898

DOI

10.1016/j.bbmt.2008.02.019

Scopus ID

2-s2.0-41949142667 (requires institutional sign-in at Scopus site)   37 Citations

Abstract

Hematopoietic stem cell transplantation (HSCT) is an integral part of the treatment of many patients with acute myeloid leukemia (AML). Despite extensive study, the appropriate role and timing of allogeneic and autologous transplantation in AML are poorly defined. This review critically analyzes the extensive literature, focusing on the recent advances, and provides practical recommendations for the use of HSCT in AML.

Author List

Hamadani M, Awan FT, Copelan EA

Author

Mehdi Hamadani MBBS Professor in the Medicine department at Medical College of Wisconsin




MESH terms used to index this publication - Major topics in bold

Graft vs Leukemia Effect
Hematopoietic Stem Cell Transplantation
Humans
Leukemia, Myeloid, Acute
Practice Guidelines as Topic
Transplantation Conditioning